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A synthesis of the naturally occurring xanthone toxyloxanthone B is described, in which the key step is
the regioselective addition of a methyl salicylate to a substituted benzyne, followed by cyclization of the
intermediate aryl anion to form the xanthone, the regiochemistry of the aryne addition being conﬁrmed
by X-ray crystallography. Subsequent introduction of the pyran ring by [3,3]-rearrangement and de-
protection completed the synthesis.
 2014 Elsevier Ltd. All rights reserved.1. Introduction
Xanthones are widely distributed in Nature, occurring in a wide
range of organisms from bacteria to higher plants.1 Not only are
xanthones highly colored (Greek xanthos¼yellow), they are also
endowed with signiﬁcant biological activity. Plants and trees of the
Garcinia genus are a particularly rich source of bioactive xanthones,
and recently isolated examples possess activity against platelet
aggregation,2 a-glucosidases,3 cancer,4 and MRSA.5,6 In higher
plants, xanthones are of mixed polyketide and shikimic acid bio-
synthetic origin, with many examples also possessing isoprene-Fig. 1. Some naturally occurrin
e-mail address: c.j.moody@
All rights reserved.derived side chains.3e5 Indeed it was prenylated xanthones such
as a-mangostin 1, rubraxanthone 2, and toxyloxanthone B 3a (Fig.1)
that attracted our attention. a-Mangostin 1, from Garcinia man-
gostana, is a potent inhibitor of sphingomyelinase,7,8 whereas
rubraxanthone 2, isolated from various members of the Garcinia
genus,9,10 has a range of biological properties.11,12 The cytotoxic
xanthone toxyloxanthone B 3a on the other hand is not Garcinia-
derived being originally isolated fromMaclura pomifera and Toxylon
pomiferum,13e16 and subsequently from the Hypericum genus, in-
cluding Hypericum perforatum (St John’s Wort).17,18 Surprisingly,
despite their relative structural simplicity, a-mangostin 1 is the onlyg prenylated xanthones.one of the three compounds to be synthesized.8 We now report the
synthesis of toxyloxanthone 3 that not only constitutes the ﬁrst
synthesis of the natural material, but also, as far as we are aware,
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by Larock19,20 in the synthesis of bioactive natural products.2. Results and discussion
The toxyloxanthones were ﬁrst isolated from M. pomifera,13 al-
though the originally assigned structure of toxyloxanthone B was
corrected some two years later. Speciﬁcally, the position of the two
methyl groups at C-3 was conﬁrmed by NMR spectroscopy,14 and
subsequently conﬁrmed by an unambiguous synthesis of the tri-
methyl ether 3b,15,16 although the natural product itself has not
been synthesized. In common with many other routes to xan-
thones, the synthesis of toxyloxanthone B trimethyl ether 3b was
achieved in a classical sense by way of a suitably substituted ben-
zophenone,16 but we were attracted by the more contemporary
aryne-based method introduced by Larock.19,20 There has been
a recent resurgence in interest in aryne chemistry, and their ap-
plication in natural product synthesis is extremely topical.21e23 The
Larock method involves the nucleophilic addition of the hydroxy
group of a methyl salicylate to a benzyne followed by cyclization of
the resulting aryl anion onto the methyl ester (Scheme 1). In the
case of toxyloxanthone B 3a, the required coupling partners would
be the methyl salicylate 4 and the ortho-trimethylsilyl triﬂate aryne
precursor 5, with benzyl protecting groups chosen for the three
phenolic hydroxy groups, with the remaining phenol in 4 orthog-
onally protected as its MOM-ether. The substituted benzyne de-
rived from precursor 5 is unsymmetrical and therefore could lead
to two nucleophilic addition products. However, Stoltz and co-
workers have previously shown that the aryne derived from 5
undergoes regioselective attack as indicated in Scheme 1,24 and
thereforewewere conﬁdent that the correct xanthonewould result
from our projected coupling reaction.Scheme 1. Larock benzyne-based route to xanthones, and the proposed precursors to
toxyloxanthone B.
Scheme 2. Reagents and conditions: (a) BnBr, K2CO3, acetone, rt (82%); (b) K2S2O8,
NaOH, water, rt (15%þ64% recovered 7); (c) MOMCl, i-Pr2NEt, CH2Cl2, rt (70%); (d) NaH,
CsF, THF, 65 C (40%þ30% 10); (e) LiOH, MeOH, aq THF, then TFAA, CH2Cl2, rt (99%); (f)
TFA, CH2Cl2, rt (94%); (g) MgBr2, toluene, reﬂux (10%); (h) HCCCMe2Cl, KI, K2CO3, ac-
etone, reﬂux (75%); (i) toluene, reﬂux (100%); (j) BCl3 (1 M in hexane), pentam-
ethylbenzene, CH2Cl2, 78 C, then rt (64%).The methyl salicylate 4 was obtained from methyl 2,4-
hydroxybenzoate 6 by selective protection of the non-hydrogen
bonded phenol to give salicylate 7. Subsequent Elbs persulfate ox-
idation25 gave the hydroquinone 8 albeit in poor yield, although the
64% recovery of starting material 7 rendered the process viable.
Selective protection of the non-hydrogen bonded phenol as its
MOM-ether gave the required methyl salicylate 4 (Scheme 2). The
aryne precursor 5 was prepared from phloroglucinol as described
by Stoltz and co-workers,24 setting the stage for the key step.
Generation of the aryne from the triﬂate 5 with cesium ﬂuoride inTHF in the presence of the methyl salicylate 4 as described by
Larock and co-workers gave the desired xanthone 9, but in 1:1
admixture with the ortho-aryloxy benzoate 10 (Scheme 2). Rea-
soning that the only source of protonation of the intermediate aryl
anion was the salicylate 4 itself, a change in conditions involving
the addition of sodium hydride for prior deprotonation of the
phenol resulted in an improved yield (40%) of the desired xanthone
9, although the benzoate 10was still formed (30%). As expected, the
nucleophilic addition to the unsymmetrical benzyne derived from
triﬂate 5was highly regioselective resulting in the formation of the
1,3,6-tribenzyloxyxanthone 9. The alternative regioisomer, the
2,4,6-tribenzyloxyxanthone, that would result from attack on the
other aryne carbon was not observed. In terms of obtaining quan-
tities of xanthone 9, the formation of benzoate 10 was in-
consequential since ester hydrolysis and cyclization onto the
electron rich aromatic ring in the presence of triﬂuoroacetic acid
anhydride provided further material.
With the xanthone 9 available in quantity, the MOM-ether was
cleaved under acidic conditions, and the resulting phenol 11 was
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to the carbonyl by treatment with magnesium bromide in boiling
toluene. The structure of the resulting phenol 12was conﬁrmed by
X-ray crystallography (Fig. 2), providing unambiguous evidence for
the regiochemistry of the aryne addition. Alkylation of phenol 11
with 3-chloro-3-methylbutyne gave the propargyl ether 13 in good
yield. Claisen rearrangement under mild conditions26 resulted in
formation of the fused pyran ring to give protected toxyloxanthone
14 in quantitative yield (Scheme 2). The ﬁnal step required the
removal of three benzyl protecting groups, and although this could
not be carried out under catalytic transfer hydrogenation with
ammonium formate as hydrogen donor,27 treatment with boron
trichloride in dichloromethane in the presence of pentam-
ethylbenzene28 at 78 C initially removed two of the benzyl
groups. For full deprotection, the reaction mixture required
warming to room temperature with extra boron trichloride, which
pleasingly gave the xanthone 3a (toxyloxanthone) in 64% yield.Fig. 2. X-ray crystal structure of 3,6-dibenzyloxy-1,7-dihydroxy-9H-xanthen-9-one 12
(with one molecule of chloroform) CCDC number 973933.The 1H spectroscopic properties of the synthetic material closely
matched those described for the natural product,17,18 although the
13C NMR gave a systematic difference in the chemical shifts of
0.8e1.1 ppm.We assumed that this was due to incorrect calibration
of the original spectrum, and indeed when we re-referenced the
residual acetone peak, a near perfect match to the reported litera-
ture values was observed. Additionally, for further comparison,
toxyloxanthone B 3awas converted into the known trimethyl ether
3b by reaction with dimethyl sulfate, the 1H NMR spectroscopic
data of which were identical with those reported.16 The ﬁrst syn-
thesis of the naturally occurring xanthone toxyloxanthone B fur-
ther demonstrates the use of arynes in synthesis, and in particular
that the Larock xanthone methodology can be successfully applied
in the synthesis of relatively complex natural products.
3. Experimental section
3.1. General information
Commercially available reagents were used throughout without
puriﬁcation unless otherwise stated. All anhydrous solvents were
used as supplied, except tetrahydrofuran and dichloromethane that
were freshly distilled according to standard procedures. Reactions
were routinely carried out under an argon atmosphere unless
otherwise stated, and all glassware was ﬂame-dried before use.
Light petroleum refers to the fraction with bp 40e60 C. Ether re-
fers to diethyl ether.
Analytical thin layer chromatography was carried out on alu-
minum backed plates coated with silica gel, and visualized under
UV light at 254 and/or 360 nm and/or by chemical staining. Flash
chromatography was carried out using silica gel, with the eluant
speciﬁed.
Infrared spectrawere recorded using an FT-IR spectrometer over
the range 4000e600 cm1. NMR spectra were recorded at 400 or
500 MHz (1H frequency, 100 or 125 MHz 13C frequency). Chemicalshifts are quoted in parts per million (ppm), and are referenced to
residual H in the deuterated solvent as the internal standard.
Coupling constants, J, are quoted in hertz (Hz). In the 13C NMR
spectra, signals corresponding to CH, CH2, or CH3 groups are
assigned fromDEPT. Mass spectrawere recorded on a time-of-ﬂight
mass spectrometer using electrospray ionization (ESI), or an EI
magnetic sector instrument.3.2. 3,5-Dibenzyloxy-2-trimethylsilylphenyl triﬂuoromethane
sulfonate 5The title compound was prepared by the method of Stoltz and
co-workers.24
3.3. Methyl 4-benzyloxy-2-hydroxybenzoate 7A mixture of methyl 2,4-dihydroxybenzoate 6 (4.00 g,
23.8 mmol) and anhydrous potassium carbonate (4.90 g,
35.7 mmol) in acetone (22 mL) was stirred at room temperature for
5 min. Benzyl bromide (2.83 mL, 23.8 mmol) was added dropwise
and the mixture was stirred at 10e15 C for 3 h. Water (30 mL) and
ethyl acetate (30 mL) were added and the two phases were sepa-
rated. The aqueous phase was extracted with further ethyl acetate
(340 mL). The combined organic layers were washed with brine
(40 mL), dried over MgSO4, ﬁltered, and concentrated under re-
duced pressure. The residue was puriﬁed by ﬂash column chro-
matography (9:1 light petroleum/ethyl acetate) to give the title
compound (5.06 g, 82%) as a colorless solid, mp 103e105 C (lit.,29
mp 103e105 C). Found: [MþNaþ], 281.0781. C15H14NaO4þ re-
quires 281.0784; nmax (CHCl3)/cm1 3008, 2956, 1668, 1623, 1583,
1505, 1441, 1382, 1349, 1255, 1183, 1142, 1099, 1014; dH (400 MHz;
DMSO-d6) 10.78 (1H, s), 7.74 (1H, d, J 7.2), 7.47e7.36 (5H, m),
6.64e6.61 (2H, m), 5.18 (2H, s), 3.88 (3H, s); dC (100MHz; DMSO-d6)
169.8 (C), 164.7 (C), 163.0 (C), 136.8 (C), 131.8 (CH), 128.9 (CH), 128.5
(CH), 128.2 (CH), 108.5 (CH), 105.9 (C), 102.4 (CH), 70.1 (CH2), 52.7
(Me).
3.4. Methyl 4-benzyloxy-2,5-dihydroxybenzoate 8To a stirred mixture of methyl 4-benzyloxy-2-hydroxybenzoate
7 (3.50 g, 13.5 mmol) in an aqueous solution of NaOH (1 M; 135mL)
at 0 C was added over 30 min, a solution of potassium persulfate
(7.70 g, 28.5mmol) inwater (135mL). After stirring for 20 h at room
temperature, the reaction mixture was acidiﬁed to pH 4 with
concentrated hydrochloric acid. The mixture was ﬁltered to remove
the unreacted starting material (2.25 g, 64% recovery). Further
concentrated hydrochloric acid (30 mL) was added to the aqueous
phase and themixture heated to 80 C for 2 h. After cooling to room
temperature, ethyl acetate (150 mL) was added, and then the
aqueous layer was extracted with further ethyl acetate (3200mL).
The combined organic phases were dried over MgSO4 and
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matography (9:1 light petroleum/ethyl acetate). The product was
crystallized frommethanol to give the title compound as a colorless
solid (560 mg, 15%), mp 165e167 C. Found: [MþNaþ], 297.0716.
C15H14NaO5
þ requires 297.0733; nmax (CHCl3)/cm1 3684, 3555,
3011, 2956, 1669, 1635, 1509, 1440, 1399, 1374, 1276, 1239, 1168,
1082, 1000; dH (400 MHz; DMSO-d6) 10.33 (1H, s), 8.94 (1H, s),
7.50e7.35 (5H, m), 7.18 (1H, s), 6.63 (1H, s), 5.18 (2H, s), 3.86 (3H, s);
dC (100 MHz; DMSO-d6) 170.0 (C), 156.1 (C), 154.2 (C), 140.1 (C),
136.9 (C), 128.9 (CH), 128.4 (CH), 128.2 (CH), 114.4 (CH), 103.7 (C),
102.1 (CH), 70.2 (CH2), 52.6 (Me).3.5. Methyl 4-benzyloxy-2-hydroxy-5-methoxymethoxybenzo
ate 4To a solution of methyl 4-benzyloxy-2,5-dihydroxybenzoate 8
(450mg,1.64mmol) in dichloromethane (18mL) at 0 C, was added
DIPEA (0.51 mL, 2.95 mmol), and after a few minutes, MOMCl
(0.14 mL, 1.8 mmol). The mixture was stirred for 2 h at room tem-
perature. Water (15 mL) was added and the mixture was extracted
with ethyl acetate (315 mL). The combined organic extract was
dried over MgSO4, and evaporated. The residue was puriﬁed by
ﬂash column chromatography (9:1 light petroleum/ethyl acetate)
to give the title compound as a colorless solid (410 mg, 70%), mp
103e105 C. Found: [MþNaþ], 341.0994. C17H18NaO6þ requires
341.0996; nmax (CHCl3)/cm1 3154, 3011, 2955, 1668, 1620, 1511,
1497, 1441, 1355, 1259, 1192, 1162, 1097, 1070, 988; dH (400 MHz;
DMSO-d6) 10.58 (1H, s), 7.48e7.37 (6H, m), 6.73 (1H, s), 5.20 (2H, s),
5.09 (2H, s), 3.88 (3H, s), 3.39 (3H, s); dC (100 MHz; DMSO-d6) 169.7
(C), 158.4 (C), 156.3 (C), 139.5 (C), 136.6 (C), 129.0 (CH), 128.6 (CH),
128.3 (CH), 117.8 (CH), 103.9 (C), 102.4 (CH), 96.2 (CH2), 70.5 (CH2),
56.2 (Me), 52.7 (Me).3.6. 1,3,6-Tribenzyloxy-7-methoxymethoxy-9H-xanthen-9-
one 9To a solution of methyl 4-benzyloxy-2-hydroxy-5-
methoxymethoxybenzoate 4 (409 mg, 1.28 mmol) in THF
(15 mL) at room temperature was added sodium hydride ([60%
dispersion in mineral oil] 52 mg, 1.29 mmol) and the mixture was
left to stir for 45 min. The mixture was heated to 65 C and cesium
ﬂuoride (780 mg, 5.14 mmol) was added, followed by a solution of
3,5-dibenzyloxy-2-trimethylsilylphenyl triﬂuoromethanesulfonate
5 (720mg,1.41mmol) in THF (10mL), over 30min. Themixturewas
stirred for 24 h at 65 C, then cooled, diluted with ether (100 mL),
and washed with brine (100 mL). The aqueous layer was extracted
with ethyl acetate (260 mL), the combined organic extracts dried
over MgSO4, ﬁltered, and evaporated. The residue was puriﬁed by
ﬂash column chromatography (8:2 light petroleum/ethyl acetate)
to give the title compound as a light brown solid (295 mg, 40%), mp
148e150 C. Found: [MþHþ], 575.2062. C36H31O7þ requires
575.2064; nmax (CHCl3)/cm1 3068, 3010, 2931, 1715, 1644, 1624,
1606, 1499, 1453, 1438, 1376, 1268, 1182, 1156, 1122, 1076; dH
(400MHz; CDCl3) 8.00 (1H, s), 7.67 (2H, d, J 7.1), 7.51e7.34 (13H, m),
6.87 (1H, s, H-5), 6.55 (1H, d, J 2.3), 6.50 (1H, d, J 2.3), 5.31 (2H, s),5.27 (2H, s), 5.25 (2H, s), 5.14 (2H, s), 3.56 (3H, s); dC (100 MHz;
CDCl3) 174.3 (C), 163.3 (C), 160.7 (C), 159.7 (C), 154.6 (C), 151.6 (C),
143.9 (C), 136.4 (C), 135.9 (C), 135.8 (C), 128.8 (CH2), 128.6 (CH),
128.4 (CH), 128.3 (CH), 127.7 (CH), 127.6 (CH), 127.2 (CH), 126.8 (CH),
116.6 (C), 113.2 (CH), 107.5 (C), 101.0 (CH), 97.2 (CH), 96.1 (CH2), 94.0
(CH), 71.0 (CH2), 70.8 (CH2), 70.5 (CH2), 56.4 (Me).
Also formed was methyl 4-benzyloxy-2-(3,5-dibenzyloxy)phe-
noxy-5-methoxymethoxybenzoate 10 (235 mg, 30%), mp 70e71 C.
Found: [MþNaþ], 629.2125. C37H34NaO8þ requires 629.2146; nmax
(CHCl3)/cm1 3091, 3068, 3009, 1715, 1605, 1509, 1455, 1265, 1155,
1129; dH (400 MHz; CDCl3) 7.73 (1H, s), 7.44e7.28 (15H, m), 6.60
(1H, s), 6.35 (1H, t, J 2.1), 6.12 (2H, d, J 2.1), 5.24 (2H, s), 5.05 (2H, s),
4.97 (4H, s), 3.75 (3H, s), 2.90 (3H, s); dC (100MHz; CDCl3) 165.0 (C),
160.7 (C), 160.3 (C), 153.6 (C), 151.5 (C), 143.1 (C), 136.7 (C), 135.8 (C),
128.7 (CH),128.6 (CH),128.2 (CH), 128.1 (CH),127.6 (CH),127.4 (CH),
120.1 (CH), 115.3 (C), 108.0 (CH), 96.9 (CH), 96.5 (CH), 96.1 (CH2),
70.7 (CH2), 70.1 (CH2), 56.5 (Me), 52.0 (Me).
3.7. 1,3,6-Tribenzyloxy-7-methoxymethoxy-9H-xanthen-9-
one 9 (method 2)
To a solution of methyl 4-benzyloxy-2-(3,5-dibenzyloxy)phe-
noxy-5-methoxymethoxybenzoate 10 (500 mg, 0.83 mmol) in
methanol (14 mL) at 0 C was added a solution of LiOH (395 mg,
16.5 mmol) in a mixture of THF/water (1:1, 7 mL), and the mixture
was stirred at room temperature for 7 h. The mixture was concen-
trated under reducedpressure, the residue dilutedwithwater (5mL)
andacidiﬁed topH6withhydrochloric acid (2M), and thenextracted
with ethyl acetate (320 mL). The combined organic extracts were
driedwith MgSO4 and concentrated under reduced pressure, to give
the benzoic acid that was used immediately in the next step.
The above acid was taken up in dichloromethane (9 mL) and the
solution cooled to 0 C. Triﬂuoroacetic anhydride (0.69 mL,
4.95 mmol) was added slowly and the mixture was stirred for 3 h at
room temperature. After this period, the mixture was concentrated
under reduced pressure and diluted with a saturated solution of
sodium hydrogen carbonate (10 mL). The mixture was extracted
with dichloromethane (315 mL) and the combined organic frac-
tions were dried over MgSO4 and concentrated under reduced
pressure to give the title compound as a light brown solid (465 mg,
99%) that did not require further puriﬁcation.
3.8. 7-Hydroxy-1,3,6-tribenzyloxy-9H-xanthen-9-one 11
To a solution of 1,3,6-tribenzyloxy-7-methoxymethoxy-9H-
xanthen-9-one 9 (380 mg, 0.66 mmol) in anhydrous dichloro-
methane (24 mL) at 0 C was added triﬂuoroacetic acid (4 mL), and
the reaction mixture was stirred for 30 min at room temperature.
Saturated aqueous sodium hydrogen carbonate (30 mL) was added
slowly and the mixture extracted with ethyl acetate (330 mL). The
combined organic extracts were washed with saturated brine
(10mL), dried overMgSO4, ﬁltered, and concentrated under reduced
pressure. The residual oil was puriﬁed by ﬂash column chroma-
tography (7:3 light petroleum/ethyl acetate) to give the title
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[MþHþ], 531.1814. C34H27O6þ requires 531.1802; nmax (CHCl3)/cm1
3687, 3603, 3011,1630,1602,1500,1438,1272,1239,1174,1118,1017;
dH (400 MHz; CDCl3) 7.82 (1H, s), 7.62 (2H, d, J 7.3), 7.48e7.35 (13H,
m), 6.91 (1H, s), 6.54 (1H, s), 6.48 (1H, s), 5.27 (2H, s), 5.24 (2H, s),
5.13 (2H, s); dC (100 MHz; CDCl3) 175.0 (C), 163.5 (C), 160.7 (C), 159.8
(C), 151.2 (C), 150.2 (C), 143.0 (C), 136.3 (C), 135.7 (C), 135.0 (C), 129.0
(CH), 128.9 (CH), 128.8 (CH), 128.7 (CH), 128.4 (CH), 127.9 (CH), 127.8
(CH),127.6 (CH),126.8 (CH),117.0 (C),109.9 (CH), 107.3 (C), 99.6 (CH),
97.1 (CH), 94.0 (CH), 71.6 (CH2), 70.8 (CH2), 70.5 (CH2).
3.9. 3,6-Dibenzyloxy-1,7-dihydroxy-9H-xanthen-9-one 12Anhydrous magnesium bromide (118 mg, 0.641 mmol) was
added to 7-hydroxy-1,3,6-tribenzyloxy-9H-xanthen-9-one 11
(68 mg, 0.128 mmol) in toluene (2 mL) and the yellow suspension
was heated to reﬂux and stirred for 15 h, turning deep red. Hydro-
chloric acid (5mL)was added, and the aqueous phasewas extracted
with ethyl acetate (310 mL). The combined organic extracts were
washed with water (30 mL) and brine (30 mL), dried (MgSO4), and
concentrated under reduced pressure. The residue was puriﬁed by
ﬂash column chromatography (2:3 ethyl acetate/light petroleum) to
give the title compound as a pale yellow solid (5 mg, 10%); mp
173e174 C. Found: [MþNaþ], 463.1149. C27H20NaO6þ requires
463.1200; nmax (CHCl3)/cm1 3632, 3550, 3071, 3013, 2947, 2890,
2852, 1654, 1614, 1488, 1289, 1174; dH (400 MHz; DMSO-d6) 13.07
(1H, s), 9.87 (1H, s), 7.53e7.56 (10H, m), 7.23e7.21 (2H, m), 6.65 (1H,
d, J 2.2), 6.46 (1H, d, J 2.2), 5.31 (2H, s), 5.25 (2H, s); dC (100 MHz;
DMSO-d6) 179.6 (C),165.2 (C),162.8 (C),157.6 (C),154.7 (C),151.2 (C),
145.2 (C),136.6 (C 2),129.0 (CH),128.8 (CH),128.7 (CH),128.6 (CH),
128.43 (CH), 128.40 (CH), 113.3 (C), 108.2 (CH), 103.2 (C), 101.8 (CH),
97.9 (CH), 93.7 (CH), 70.8 (CH2), 70.5 (CH2).3.10. 7-(2,2-Dimethylbut-3-ynyl)-1,3,6-tribenzyloxy-9H-
xanthen-9-one 13Potassium carbonate (82mg, 0.594mmol) and potassium iodide
(82 mg, 0.49 mmol) were added to a solution of 7-hydroxy-1,3,6-
tribenzyloxy-9H-xanthen-9-one 11 (150 mg, 0.283 mmol) in ace-
tone (15 mL). 3-Chloro-3-methyl-1-butyne (80 mL, 0.707 mmol)
was added in a single portion and the reaction mixture was heated
to reﬂux and stirred for 48 h. After cooling, ether (60 mL) was
added, and the ethereal solution was washed with aqueous NaOH
(1 M; 310 mL). The organic layer was dried over MgSO4 and
concentrated under reduced pressure to give a solid. This was pu-
riﬁed by ﬂash column chromatography (8:2 light petroleum/ethyl
acetate) to give the title compound as a colorless solid (125mg, 75%),
mp 161e163 C. Found: [MþHþ], 597.2287. C39H33O6þ requires
597.2272; nmax (CHCl3)/cm1 3305, 3011, 1645, 1623, 1605, 1498,
1443, 1379, 1270, 1182, 1119, 1048, 1028; dH (400 MHz; CDCl3) 8.28
(1H, s), 7.65 (2H, d, J 7.3), 7.52 (2H, d, J 7.3), 7.46e7.34 (11H, m), 6.89
(1H, s), 6.55 (1H, d, J 1.8), 6.49 (1H, d, J 1.8), 5.28 (2H, s), 5.20 (2H, s),
5.13 (2H, s), 2.57 (1H, s), 1.72 (6H, s); dC (100 MHz; CDCl3) 174.5 (C),163.2 (C), 160.7 (C), 159.7 (C), 157.4 (C), 152.5 (C), 142.2 (C), 136.4 (C),
136.9 (C), 135.7 (C), 128.8 (CH), 128.7 (CH), 128.6 (CH), 128.4 (CH),
128.1 (CH), 127.7 (CH), 127.6 (CH), 127.2 (CH), 126.8 (CH), 119.9 (CH),
116.4 (C),107.6 (C),100.7 (CH), 97.2 (CH), 94.1 (CH), 85.5 (C), 74.9 (C),
74.3 (CH), 70.9 (CH2), 70.8 (CH2), 70.5 (CH2), 29.6 (Me).
3.11. 5,9,11-Tribenzyloxy-3,3-dimethylpyrano[3,2-a]xanthen-
12(3H)-one 14A solution of 7-(2,2-dimethylbut-3-ynyl)-1,3,6-tribenzyloxy-
9H-xanthen-9-one 13 (10 mg, 0.02 mmol) in toluene (2 mL) was
heated under reﬂux for 2.5 h. The solvent was evaporated and the
residue puriﬁed by ﬂash column chromatography (4:1 light pe-
troleum/ethyl acetate) to give the title compound as a colorless solid
(10 mg, 100%), mp 174e175 C. Found: [MþHþ], 597.2283.
C39H33O6
þ requires 597.2272; nmax (CHCl3)/cm1 3011, 2928, 1701,
1615, 1438, 1378, 1274, 1192, 1166, 1125, 1059, 1016; dH (400 MHz;
CDCl3) 8.14 (1H, d, J 9.8), 7.62 (2H, d, J 7.3), 7.49e7.35 (13H, m), 6.74
(1H, s), 6.48 (1H, d, J 2.1), 6.43 (1H, d, J 2.1), 5.85 (1H, d, J 9.8), 5.30
(4H, s), 5.09 (2H, s),1.53 (6H, s); dC (100MHz; CDCl3) 176.9 (C),162.9
(C), 160.5 (C), 158.8 (C), 152.3 (C), 151.3 (C), 139.8 (C), 136.6 (C), 136.4
(C), 135.8 (C), 131.8 (CH), 128.8 (CH), 128.7 (CH), 128.6 (CH), 128.4
(CH), 128.0 (CH), 127.6 (CH2), 126.9 (CH), 126.7 (CH), 121.6 (CH),
120.9 (C), 111.8 (C), 108.5 (C), 101.1 (CH), 97.3 (CH), 93.5 (CH), 75.3
(C), 70.8 (CH2), 70.7 (CH2), 70.4 (CH2), 27.1 (Me).3.12. 5,9,11-Trihydroxy-3,3-dimethylpyrano[3,2-a]xanthen-
12(3H)-one (toxyloxanthone B) 3aTo a stirred solution of 5,9,11-tribenzyloxy-3,3-dimethylpyrano
[3,2-a]xanthen-12(3H)-one 14 (2 mg, 0.005 mmol), and pentam-
ethylbenzene (7 mg, 0.048 mmol) in dry dichloromethane (1 mL) at
78 Cwas added BCl3 (solution 1.0M in dichloromethane; 0.03mL)
dropwise over 10 min. After 30 min at 78 C, the reaction mixture
was warmed to room temperature and stirred for 16 h. TLC and MS
analysis showed thepresenceof themono-benzylated compound, so
extra BCl3 (solution 1.0 M in dichloromethane; 0.03 mL) was added
and the reaction mixture was stirred for a further 1 h, before being
quenched with a mixture of chloroform and methanol (9:1, 2 mL).
The excess solvent was removed under reduced pressure. The resi-
duewas puriﬁedbyﬂash chromatography (4:1 light petroleum/ethyl
acetate) to give the title compound as a pale yellow solid (1mg, 64%),
mp 318e319 C (lit.,17 mp 304e306 C). Found: [MþHþ], 327.0864.
C18H15O6
þ requires 327.0863; nmax (CHCl3)/cm1 3691, 3607, 1701,
1602, 1456, 1249, 1028, 850; dH (500 MHz; acetone-d6) 13.38 (1H, s,
11-OH), 9.60 (1H, br s, 5-OH), 9.18 (1H, br s, 9-OH), 8.03 (1H, d, J 10.2,
H-1), 6.82 (1H, s, H-6), 6.34 (1H, d, J 2.1, H-8), 6.21 (1H, d, J 2.1, H-10),
5.94 (1H, d, J 10.2, H-2),1.46 (6H, s,Me-13); dC (125MHz; acetone-d6)
180.5 (C]O), 165.3 (C-7a), 163.3 (C-11), 157.0 (C-9), 157.0 (C-6a),
155.6 (C-5), 141.3 (C-4a), 129.6 (CH-2), 122.2 (CH-1), 118.0 (C-12b),
103.2 (CH-6), 102.0 (C-11a), 101.6 (C-12a), 97.6 (CH-10), 93.0 (CH-8),
74.9 (C-3), 26.2 (Me-13).
D. Giallombardo et al. / Tetrahedron 70 (2014) 1283e128812883.13. 5,9,11-Trimethoxy-3,3-dimethylpyrano[3,2-a]xanthen-
12(3H)-one (toxyloxanthone B trimethyl ether) 3bTo a stirred solution of 5,9,11-trihydroxy-3,3-dimethylpyrano
[3,2-a]xanthen-12(3H)-one 3a (2 mg, 0.006 mmol), and anhy-
drous potassium carbonate (5 mg, 0.037 mmol) in acetone
(1 mL) was added dimethyl sulfate (0.002 mL) and the mixture was
heated to reﬂux and stirred for 16 h. The excess of solvents was
removed under reduced pressure and the residue was puriﬁed by
ﬂash chromatography (4:1 light petroleum/ethyl acetate to 2:1
light petroleum/ethyl acetate) to give the title compound as a col-
orless solid (2 mg, 89%), mp 125e126 C (lit.,16 mp 192e193 C).
Found: [MþHþ], 369.1343. C21H21O6þ requires 369.1333; nmax
(CHCl3)/cm1 3156, 2903, 2254, 1795, 1618, 1467, 1383, 1097, 905,
650; dH (500 MHz; acetone-d6) 8.10 (1H, d, J 10.2, H-1), 6.73 (1H, s,
H-6), 6.42 (1H, d, J 2.3, H-8), 6.32 (1H, d, J 2.3, H-10), 5.77 (1H, d, J
10.2, H-2), 3.97 (3H, s, 11-OMe), 3.95 (3H, s, 5-OMe), 3.90 (3H, s, 9-
OMe), 1.48 (6H, s, 3-Me); dC (125 MHz; acetone-d6) 177.2 (C), 164.1
(C), 161.8 (C), 158.9 (C), 153.4 (C), 151.6 (C), 139.2 (C), 131.6 (CH),
121.5 (CH), 120.7 (C), 111.2 (CH), 107.9 (C), 98.7 (C), 95.0 (CH), 92.1
(CH), 75.4 (C), 56.3 (OMe), 56.2 (OMe), 55.6 (OMe), 27.1 (Me).
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